Soleno Therapeutics (SLNO) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 19,397.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,397.00 |
| Dec 31, 2025 | 11,308.00 |
| Sep 30, 2025 | 5,984.00 |
| Jun 30, 2025 | 1,047.00 |
| Mar 31, 2025 | 2,070.00 |
| Dec 31, 2024 | 3,794.00 |
| Sep 30, 2024 | 4,969.00 |
| Jun 30, 2024 | 4,929.00 |
| Mar 31, 2024 | 3,549.00 |
| Dec 31, 2023 | 2,331.00 |
| Sep 30, 2023 | -12,914.00 |
| Jun 30, 2023 | -10,521.00 |
| Mar 31, 2023 | -7,784.00 |
| Dec 31, 2022 | -2,882.00 |
| Sep 30, 2022 | -801.00 |
| Jun 30, 2022 | -1,991.00 |
| Mar 31, 2022 | -4,791.00 |
| Dec 31, 2021 | -6,081.00 |
| Sep 30, 2021 | -4,563.00 |
| Jun 30, 2021 | -3,650.00 |
| Mar 31, 2021 | -3,050.00 |
| Dec 31, 2020 | -2,142.00 |
| Sep 30, 2020 | -1,907.00 |
| Jun 30, 2020 | -4,365.00 |
| Mar 31, 2020 | -5,719.00 |
| Dec 31, 2019 | 11,564.00 |
| Sep 30, 2019 | 16,142.00 |
| Jun 30, 2019 | 18,466.00 |
| Mar 31, 2019 | 18,438.00 |
| Dec 31, 2018 | 22,641.00 |
| Sep 30, 2018 | 47,070.00 |
| Jun 30, 2018 | -26,453.00 |
| Mar 31, 2018 | 4,451.00 |
| Dec 31, 2017 | 9,807.00 |